Technology | 2009.06.11
Biosystems International Establishes Licensing Agreement with Lohocla Research Institute to Search for Novel Alcoholism Liver Disease Biomarkers
PARIS--(BUSINESS WIRE)--Biosystems International (BSI) a biotechnology company focused on the development of novel monoclonal antibody-based diagnostics for cancer and metabolic diseases has established a licensing
For more information, please visit
http://www.businesswire.com/news/home/20090611005296/en
